We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to Kenvue (KVUE) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
Analysts on Wall Street project that Kenvue (KVUE - Free Report) will announce quarterly earnings of $0.28 per share in its forthcoming report, representing a decline of 12.5% year over year. Revenues are projected to reach $3.86 billion, declining 3.5% from the same quarter last year.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 1.3% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Kenvue metrics that are routinely monitored and predicted by Wall Street analysts.
According to the collective judgment of analysts, 'Net Sales- Self Care' should come in at $1.60 billion. The estimate points to a change of -2.2% from the year-ago quarter.
Analysts predict that the 'Net Sales- Essential Health' will reach $1.23 billion. The estimate indicates a change of -2.4% from the prior-year quarter.
The combined assessment of analysts suggests that 'Net Sales- Skin Health and Beauty' will likely reach $1.04 billion. The estimate points to a change of -6% from the year-ago quarter.
Shares of Kenvue have demonstrated returns of +2.6% over the past month compared to the Zacks S&P 500 composite's +0.6% change. With a Zacks Rank #4 (Sell), KVUE is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Countdown to Kenvue (KVUE) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Analysts on Wall Street project that Kenvue (KVUE - Free Report) will announce quarterly earnings of $0.28 per share in its forthcoming report, representing a decline of 12.5% year over year. Revenues are projected to reach $3.86 billion, declining 3.5% from the same quarter last year.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 1.3% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Kenvue metrics that are routinely monitored and predicted by Wall Street analysts.
According to the collective judgment of analysts, 'Net Sales- Self Care' should come in at $1.60 billion. The estimate points to a change of -2.2% from the year-ago quarter.
Analysts predict that the 'Net Sales- Essential Health' will reach $1.23 billion. The estimate indicates a change of -2.4% from the prior-year quarter.
The combined assessment of analysts suggests that 'Net Sales- Skin Health and Beauty' will likely reach $1.04 billion. The estimate points to a change of -6% from the year-ago quarter.
View all Key Company Metrics for Kenvue here>>>Shares of Kenvue have demonstrated returns of +2.6% over the past month compared to the Zacks S&P 500 composite's +0.6% change. With a Zacks Rank #4 (Sell), KVUE is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .